A retrospective study assessing the treatment tolerability, cosmetic outcomes, and efficacy of sequential treatment with topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% cream for Superficial Basal Cell Carcinomas
Latest Information Update: 22 Jan 2021
At a glance
- Drugs Imiquimod (Primary) ; Methyl aminolevulinate (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 22 Jan 2021 New trial record